Radio
Now Playing
Quickyla Radio โ€” Click to play
Open โ†’
3 min left
Back to News

Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases

Cabaletta Bio Inc. (NASDAQ: CABA ) is one of the top penny stocks to buy in investorsโ€™ stock portfolio . On May 14, Cabaletta Bio Inc. (NASDAQ:CABA) delivered positive clinical and translational data from the first four patients in the lowest dose cohort evaluating preconditionin

Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases
Yahoo Finance โ€” 7 June 2026
Text:
7 0 0

Cabaletta Bio Inc. (NASDAQ: CABA ) is one of the top penny stocks to buy in investorsโ€™ stock portfolio . On May 14, Cabaletta Bio Inc. (NASDAQ:CABA) delivered positive clinical and translational data from the first four patients in the lowest dose cohort evaluating preconditioning-free (PC-free) rese-cel, an investigational, autologous CAR T cell therapy for the treatment of autoimmune diseases.

It also presented manufacturing and translational data from the first two autoimmune patients treated with rese-cel treated using Cellares Cell Shuttle platform. It became clear that a higher rese-cel dose would be required in the absence of preconditioning. In addition, 50% of the patients demonstrated compelling, drug-free responses for six months.

Consequently, PC-free rese-cel has the potential to enhance access for patients in CAR T centers. The company has already signed a long-term commercial supply agreement that will ensure rese-cel is produced for thousands of patients at the lowest cost of goods, with minimal capital investment.

Cabaletta is on track to announce initial data from the lowest-dose cohort of lupus patients dosed with preconditioning. The company also plans to advance rese-cel toward BLA submission as it eyes a commercial launch.

Cabaletta Bio is a clinical-stage biotechnology company developing engineered T-cell therapies designed to reset the immune system and provide potentially curative treatments for patients with autoimmune diseases.

While we acknowledge the potential of CABA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .

READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks .

Advertisement
React:
Sources
Sponsored

More to Read

Sam Altman says OpenAI's top token spender uses 100 billionโ€ฆ
๐Ÿ“ˆ Markets & Finance
Sam Altman says OpenAI's top token spender uses 100 billion tokens a month โ€” and they're โ€ฆ
Business Insider Mkt ยท 10 days ago
Intel, AMD, Micron shares sink as Broadcom results spark seโ€ฆ
๐Ÿ“ˆ Markets & Finance
Intel, AMD, Micron shares sink as Broadcom results spark semiconductor sector sell-off
Yahoo Finance ยท 9 days ago
This Smartโ€‘Money Legend Won Big on Intel. The Rest of His Pโ€ฆ
๐Ÿ“ˆ Markets & Finance
This Smartโ€‘Money Legend Won Big on Intel. The Rest of His Portfolio Might Be Even More Reโ€ฆ
Yahoo Finance ยท 12 days ago
CBS News insiders worry how 60 Minutes will endure after fiโ€ฆ
๐Ÿ’ฐ Business
CBS News insiders worry how 60 Minutes will endure after firings: โ€˜What are they going toโ€ฆ
Guardian Business ยท 9 days ago
'Astonishing': James Webb telescope spots the most chemicalโ€ฆ
๐Ÿ”ฌ Science
'Astonishing': James Webb telescope spots the most chemically primitive galaxy in the ancโ€ฆ
Live Science ยท 13 days ago
Donโ€™t underestimate young athletes โ€” the NAACP boycott planโ€ฆ
โšฝ Sports
Donโ€™t underestimate young athletes โ€” the NAACP boycott plan could actually work
Yahoo Sports ยท 12 days ago
Full view